End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.3 CNY | +8.68% | +7.75% | +47.87% |
Apr. 25 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 19 | Henan Lingrui Pharma Registers Chewable Asthma Drug in China | MT |
Sales 2024 * | 3.96B 547M | Sales 2025 * | 4.52B 624M | Capitalization | 14.27B 1.97B |
---|---|---|---|---|---|
Net income 2024 * | 641M 88.46M | Net income 2025 * | 746M 103M | EV / Sales 2024 * | 3.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.16 x |
P/E ratio 2024 * |
22.4
x | P/E ratio 2025 * |
19.2
x | Employees | 2,524 |
Yield 2024 * |
3.48% | Yield 2025 * |
4.07% | Free-Float | 74.14% |
1 day | +8.68% | ||
1 week | +7.75% | ||
Current month | +17.95% | ||
1 month | +20.94% | ||
3 months | +48.65% | ||
6 months | +54.74% | ||
Current year | +47.87% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 40 | - |
Peng Yu
DFI | Director of Finance/CFO | 55 | - |
Jia Shu Jiang
BRD | Director/Board Member | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 40 | - |
Xi Zhen Wu
BRD | Director/Board Member | 60 | 06-04-17 |
Jun Yang
BRD | Director/Board Member | 55 | 23-05-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 25.3 | +8.68% | 20,016,350 |
24-04-25 | 23.28 | +1.13% | 4,303,415 |
24-04-24 | 23.02 | -2.99% | 10,312,180 |
24-04-23 | 23.73 | -1.00% | 8,916,497 |
24-04-22 | 23.97 | +2.09% | 7,380,619 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+47.87% | 1.97B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+0.09% | 1.65B | |
-7.89% | 1.68B | |
-12.97% | 1.53B | |
+33.40% | 1.38B | |
+34.29% | 1.3B |
- Stock Market
- Equities
- 600285 Stock